创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Introduction to IC50 Assay Technology

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-11 15:06
  • Views:

(Summary description)InnoModels Biotechnology has always been committed to providing cutting-edge biotechnology solutions to support scientists in the fields of drug discovery and disease research. Among them, the IC50 (half inhibitory concentration) measurement technology is an important innovation in the company's biological research, which provides accurate and reliable data support for key steps in the drug screening and development process.

InnoModels Biotechnology: Introduction to IC50 Assay Technology

(Summary description)InnoModels Biotechnology has always been committed to providing cutting-edge biotechnology solutions to support scientists in the fields of drug discovery and disease research. Among them, the IC50 (half inhibitory concentration) measurement technology is an important innovation in the company's biological research, which provides accurate and reliable data support for key steps in the drug screening and development process.

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-11 15:06
  • Views:
Information

InnoModels Biotechnology has always been committed to providing cutting-edge biotechnology solutions to support scientists in the fields of drug discovery and disease research. Among them, the IC50 (half inhibitory concentration) measurement technology is an important innovation in the company's biological research, which provides accurate and reliable data support for key steps in the drug screening and development process.
Definition of IC50
IC50 is the concentration of a drug or compound required to inhibit biological activity by half. It is a commonly used bioactivity assay parameter to assess the inhibitory effect of a compound on biological targets, such as enzyme activity, cell proliferation, etc. The lower the IC50 value, the stronger the inhibitory effect of the compound on the target.
InnoModels Bio's IC50 assay technology
InnoModels's IC50 assay technology provides researchers with a highly accurate, high-throughput assay solution. Below are some of the remarkable features of the technology:
1. Multi-disciplinary applicability:
InnoModels's IC50 assay technology covers a wide range of research areas, including drug discovery, life science research, and more. Whether it is for enzyme, cell, or other biomolecule activity measurement, it can provide reliable IC50 values.
2. High sensitivity:
The company adopts advanced testing instruments and sensitive bioanalytical techniques to ensure that even low concentrations of drugs or compounds can be measured accurately, which improves the credibility of experimental data.
3. Fast and efficient:
InnoModels Bio's IC50 solution is not only highly accurate, but also optimised in terms of experimental cycle time to improve the efficiency of experiments and enable researchers to obtain critical data faster.
4. Customised services:
We offer customised IC50 assay services, designed to meet the specific needs of our customers, ensuring that the unique requirements of different research projects are met to the greatest extent possible.

 


Application Areas
InnoModels Bio's IC50 assay technology has been widely used in the following areas:
Drug screening and optimisation:
Through IC50 assays, scientists are able to assess the inhibitory effects of potential drug candidates to optimise drug design and development.
Biological Research:
In biological studies, the determination of IC50 values helps researchers gain insight into the function and interaction of biomolecules.
Toxicity Assessment:
Evaluation of the toxicity of compounds in living organisms is an important application of IC50 determination in toxicological studies.
Conclusion
InnoModels Bio's IC50 assay technology is not only an innovation in the field of biological research, but also provides a reliable tool for drug discovery and development. Through continuous technological innovation and service optimisation, the company will continue to play a leading role in the field of IC50 assay, providing scientists with more advanced and efficient research tools to promote the continuous progress of science.

Keyword:

In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is like a bright star, illuminating the journey of oncology and tumor immunology drug development with its unique PDX in vivo efficacy model. Today, let's go into InnoModels Biotechnology to learn more about its industry-leading PDX in vivo efficacy model and explore its unlimited potential in drug discovery and development.
In the vast field of cancer research and drug development, InnoModels Biotechnology (Beijing) Co., Ltd. provides powerful support to scientists and doctors with its leading CDX (Cell line-derived xenograft tumor) model platform. The platform not only has diverse tumor cell lines, but also is equipped with a team of experienced experts and advanced experimental technologies, which are dedicated to promoting innovation in biomedical research and clinical treatment.
In the field of life sciences, in vitro killing experimental platform is gradually becoming an important tool for drug development and cell research. Among them, the in vitro killing experimental platform of InnoModels Biotechnology has attracted the attention of many researchers with its unique technical advantages and wide application prospects. In this paper, we will introduce in detail the features and advantages of InnoModels' in vitro killing platform and its applications in scientific research.
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is leading the forefront of tumor and tumor immunotherapy research with its unique in vivo tumor experimental platform, which is like a bright star. The platform not only integrates the most advanced technologies and experimental methods, but also devotes itself to providing a new generation of experimental animal models close to the clinic
In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.
In the broad field of tumor research and new drug development for tumor immunotherapy, InnoModels Biotechnology (Beijing) Co., Ltd. has successfully launched a high mesenchymal tumor transplantation model by virtue of its profound accumulation and technological innovation in the field of model construction, which provides strong support for tumor research and drug development. In this article, we will introduce in detail how InnoModels Biotechnology has made a breakthrough in this field, and explain the importance of high mesenchymal tumor models and their application prospects.
Previous page
1
2
42

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司